Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | TTR | P02766 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 4/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 4/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 4/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Resveratrol SCHEMBL19426 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL3704258 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL19425 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL2300985 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL17629801 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL20164915 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL15106855 | 1.00 | PTGS1 (1.00) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL3405900 | 0.97 | PTGS1 (0.95) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL31096991 | 0.97 | PTGS1 (0.95) | PTGS1KDM4ETTRLMNAMEN1 | |
| Resveratrol SCHEMBL22469907 | 0.97 | PTGS1 (0.95) | PTGS1KDM4ETTRLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 365 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078269-A1 | POLYMERIC COMPOSITIONS WITH STILBENE-BASED PROCESSING AIDS | Cambium Biomaterials, Inc. (US) | 2026-03-19 | — | — | US | claimed |
| US-20250346550-A1 | METHODS OF MODULATING ENDONUCLEASE G USING RESVERATROL AND ITS DERIVATIVES | UNIV COLORADO REGENTS (US) | 2025-11-13 | — | — | US | claimed |
| EP-4601749-A1 | ORAL COMPOSITIONS AND RELATED METHODS | Colgate-Palmolive Company (US) | 2025-08-20 | — | — | EP | claimed |
| US-20250195406-A1 | COMPOSITIONS AND METHODS OF IMPROVING THE SKIN MICROBIOME | SEED HEALTH INC. | 2025-06-19 | — | — | US | claimed |
| US-20250195405-A1 | COMPOSITIONS AND METHODS OF IMPROVING THE SKIN MICROBIOME | SEED HEALTH INC. | 2025-06-19 | — | — | US | claimed |
| CN-119950730-A | GPR84 receptor antagonists and resveratrol compositions and use thereof for treating migraine | 苏州健雄职业技术学院 | 2025-05-09 | — | — | CN | claimed |
| CN-116390645-B | Grape rich in phenol | 以色列农业和农村发展部农业研究组织(范卡尼中心) | 2025-02-25 | — | — | CN | claimed |
| US-20240350574-A1 | PHENOLIC PHYTOCHEMICALS FOR BONE METASTASIS OF CANCER | NDSU RESEARCH FOUNDATION | 2024-10-24 | — | — | US | claimed |
| US-20240342111-A1 | ISOMER-SPECIFIC NEUROPROTECTIVE EFFECT OF NATURAL RESERVATROL | UNIV SOUTH CAROLINA (US) | 2024-10-17 | — | — | US | claimed |
| EP-4444419-A2 | METHODS OF TREATING LYMPHEDEMA | Celltaxis, LLC (US) | 2024-10-16 | — | — | EP | claimed |
| WO-2023043854-A1 | ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS | Nulixir Inc. (US) | 2023-03-23 | — | — | WO | claimed |
| US-20230089605-A1 | USE OF DOXYCYCLINE, RESVERATROL, IVERMECTIN, AND RELATED CHEMICALLY MODIFIED COMPOUNDS TO TREAT OR PREVENT VIRAL INFECTIONS | Ardestat Biologics, LLC | 2023-03-23 | — | — | US | claimed |
| US-20230079480-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-03-16 | — | — | US | claimed |
| EP-4142751-A1 | FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | Figene, LLC (US) | 2023-03-08 | — | — | EP | claimed |
| WO-2023001952-A1 | CALCIUM PHOSPHATE NANOPARTICLES LOADED WITH JASMONATE TO INDUCE EFFICIENT PLANT DEFENCE RESPONSES | UNIVERSIDAD DE GRANADA (ES) | 2023-01-26 | — | — | WO | claimed |
| US-20220211619-A1 | WATER SOLUBLE COMPOSITIONS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2022-07-07 | — | — | US | claimed |
| US-11351117-B2 | Water soluble compositions and methods of making the same | Nulixir Inc. (US) | 2022-06-07 | — | — | US | claimed |
| US-20170087116-A1 | Treatment of Inflammatory and Infectious Skin Disorders | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2017-03-30 | — | — | US | claimed |
| US-20140018437-A1 | TREATMENT OF INFLAMMATORY AND INFECTIOUS SKIN DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-01-16 | — | — | US | claimed |
| EP-0925068-B1 | USE OF A PHARMACEUTICAL COMPOSITION CONTAINING POLYPHENOLS FROM GRAPES OR FROM WINE, IN PARTICULAR RESVERATROL, AND YEAST EXTRACTS | LISAPHARMA SPA (IT) | 2003-09-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346550-A1 | METHODS OF MODULATING ENDONUCLEASE G USING RESVERATROL AND ITS DERIVATIVES | ENDOD1, FEN1, RNASE1 | PTGS1 1120/4885KDM4E 1565/4885TTR 4267/4885 |
| US-20260078269-A1 | POLYMERIC COMPOSITIONS WITH STILBENE-BASED PROCESSING AIDS | SMCHD1, TERB1, NLRP3 | PTGS1 3808/4885KDM4E 1981/4885TTR 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.